Business · 19/10/2007Updated: 10/17/2026 · 1 min read
FDA Submits Proposed Information Collection for Clinical Trials Data Bank Review
Summary
The Food and Drug Administration (FDA) has submitted a proposed data collection to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in order to maintain a data bank on clinical trials for serious or life-threatening diseases.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →